CardioFlow's VitaFlow Liberty receives EU CE-MDR mark, advancing global expansion roadmap
17th June, 2024
Diversifying the company's sources of sales revenue and bolstering overall competitiveness
MicroPort CardioFlow Medtech Corporation, based in China, recently announced that its self-developed second-generation transcatheter aortic valve implantation (TAVI) device, the VitaFlow LibertyTM Transcatheter Aortic Valve and Retrievable Delivery System (VitaFlow LibertyTM), has received EU CE-MDR certification. This certification highlights VitaFlow LibertyTM as a pioneering TAVI solution, that sets a new benchmark in transcatheter heart valve treatments.
With over 47 million patients globally suffering from aortic valve stenosis and regurgitation, the prevalence rates of these conditions are on the rise due to an ageing population.
The TAVI solution provided by CardioFlow, which avoids open-heart surgery and offers various benefits like minimal trauma, quick recovery, and enhanced quality of life, is increasingly becoming a preferred choice for patients with aortic heart valve disease.
Before launching into the EU market, VitaFlow LibertyTM conducted pre-market clinical implantations at Galway University Hospital in Ireland, Rigshospitalet (Copenhagen University Hospital) in Denmark, and St Thomas' Hospital as well as Brighton & Sussex University Hospitals NHS Trust in the United Kingdom, and received very high appraisal from many well-known clinical professionals.
Medtech Special
- Clarius Mobile Health gets US FDA clearance for Clarius OB AI fetal biometric measurement tool
- Israel's Medasense partners with Nihon Kohden for distribution of pain monitoring device in Japan
- Endogenex raises $88 M Series C financing to complete pivotal trial of ReCET System for diabetes patients
- Wipro 3D and Nikon SLM Solutions partner to accelerate additive manufacturing in India
- Fortis Escorts Faridabad launches dedicated state-of-the-art spine clinic in India
- Alcon’s latest equipment breakthrough technologies, Unity VCS and Unity CS, receive US FDA 510(k) clearance
- Breakthrough in 0.05 Tesla MRI by engineering team in Hong Kong
Artificial Intelligence Breakthroughs
- Israel's Medasense partners with Nihon Kohden for distribution of pain monitoring device in Japan
- AliveCor announces dual US FDA clearance of AI technology for cardiac care
- AgileMD receives US FDA clearance for eCART to predict in-hospital clinical deterioration across medical conditions
- Juniper Biologics expands distribution rights for Caris Life Sciences' molecular profiling in the Middle East and Africa
- Fischer Medical Ventures invests in Singapore's Wonder Tech to revolutionise AI-based mental healthcare
- First portable, AI-powered diabetic retinopathy screening solution for on-the-spot diagnosis
- INOVAIT and Canada govt invest $10.7 M in AI-enhanced image-guided therapy technologies
Robots In Medtech
- Nepal's first surgical robot set to transform healthcare sector
- Apollo Cancer Centres collaborates with Accuray to launch India's first robotic stereotactic radiotherapy programme
- China-based startup Ronovo Surgical raises $44 M in series B funding round
- Meril introduces advanced surgical robotic technology MISSO in India
- SS Innovations' SSi Mantra surgical robotic system receives approval for use in Indonesia
- Zimmer Biomet partners with THINK Surgical to offer robotic system for total knee arthroplasty
- 510(k) FDA clearance for J&J company DePuy Synthes for its robotic-assisted solution for knee arthroplasty
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer